{"id":"W3129382481","doi":"10.2217/cer-2020-0267","title":"Efficacy classification of modern therapies in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ocrelizumab; Cladribine; Ofatumumab; Multiple sclerosis; Relapsing remitting; Internal medicine; Placebo; MEDLINE; Oncology; Intensive care medicine; Alternative medicine; Rituximab; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004387594,0.000164714,0.001022732,0.0008284219,0.0001299146,0.00003619186,0.0002312781,0.00009107425,0.00004960753],"category_scores_gemma":[0.003823624,0.0001271459,0.0002326746,0.001425683,0.0005477614,0.0002162112,0.0001461695,0.001002231,0.000009387128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004107603,"about_ca_system_score_gemma":0.0008398349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002740424,"about_ca_topic_score_gemma":0.00007664615,"domain_scores_codex":[0.9937113,0.003265376,0.0006894664,0.0002737487,0.001648162,0.0004119761],"domain_scores_gemma":[0.9861233,0.008677774,0.0002474658,0.000330922,0.004453756,0.0001667497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004542001,0.001707468,0.1872665,0.000355841,0.0003794309,0.00004967875,0.003062843,0.0003999931,0.7868711,0.0001439993,0.0001135676,0.01510751],"study_design_scores_gemma":[0.005327792,0.0006949479,0.7782831,0.001464234,0.00001440464,0.00001753817,0.001288413,0.001910062,0.2105471,0.0002751364,0.0001056018,0.0000716525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921694,0.004694711,0.001176864,0.0004295793,0.00006856816,0.0006937122,0.000006142677,0.000005790306,0.0007552688],"genre_scores_gemma":[0.9977134,0.001422198,0.000649229,0.000004966621,0.0001025964,0.00004922221,0.000003883704,0.00001743124,0.00003707418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5910166,"threshold_uncertainty_score":0.5184858,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.436733189315095,"score_gpt":0.4796674318923596,"score_spread":0.04293424257726453,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}